How to inform at‐risk relatives? Attitudes of 1379 Dutch patients, relatives, and members of the general population

Authors:

Abstract
The uptake of predictive DNA testing in families with a hereditary disease is n = 379), and to members of the general population via a commercial panel (n = 1,000). Attitudes of the patient and population samples generally corresponded. A majority believed that initially only first‐degree relatives should be informed, following the principles of a cascade screening approach. Most participants also thought that probands and healthcare professionals (HCPs) should be involved in informing relatives, and a large proportion believed that HCPs should contact relatives directly in cases where patients are unwilling to inform, both for untreatable and treatable conditions. Participants from the patient sample were of the opinion that HCPs should actively offer support. Our findings show that both patients and HCPs should be involved in informing at‐risk relatives of autosomal dominant diseases and suggest that relatives' ‘right to know’ was considered a dominant issue by the majority of participants. Further research is needed on how to increase proactive support in informing of at‐risk relatives.
Funding Information
  • Dutch Association of Clinical Geneticists
  • ‘Stichting Kwaliteitsgelden Patiënten Consumenten’
  • Netherlands Cardiovascular Research Initiative (CVON2015-12 eDETECT)

This publication has 30 references indexed in Scilit: